【摘要】：目的:觀(guān)察在常規(guī)西藥的基礎(chǔ)上加用益腎活血解毒湯對(duì)老年冠心病不穩(wěn)定型心絞痛的臨床療效,以及對(duì)血管內(nèi)皮功能、IL-18、和肽素(Copeptin)、hs-CRP等相關(guān)指標(biāo)水平的影響,以探索其作用機(jī)制。方法:依據(jù)UA西醫(yī)診斷及中醫(yī)證候診斷標(biāo)準(zhǔn),納入老年冠心病不穩(wěn)定型心絞痛(腎虛血瘀型)患者40例,按照隨機(jī)數(shù)字表法分組,研究組和對(duì)照組各20例。對(duì)照組采用常規(guī)西藥治療,研究組在常規(guī)西藥治療的基礎(chǔ)上加用益腎活血解毒湯,療程為4周。觀(guān)察治療前后兩組患者臨床療效和相關(guān)實(shí)驗(yàn)室指標(biāo)變化結(jié)果:1.兩組患者治療后心絞痛癥狀及靜息ECG表現(xiàn)均有改善。心絞痛療效組間治療后比較,研究組總有效率(95%)高于對(duì)照組(80%);靜息ECG表現(xiàn)比較,研究組總有效率(80%)高于對(duì)照組(70%),但差異無(wú)有統(tǒng)計(jì)學(xué)意義(P㧐0.05)。2.兩組患者治療后中醫(yī)證候積分均明顯下降,差異有統(tǒng)計(jì)學(xué)意義(P0.05);治療后研究組較對(duì)照組證候積分下降更顯著(P0.01)。3.兩組患者治療后硝酸甘油的用量均減少,組間比較,研究組總停減率(90%)高于對(duì)照組(50%),差異具有統(tǒng)計(jì)學(xué)意義(P0.05)。4兩組患者治療后血管內(nèi)皮功能均(NO、6-keto-PGF1α水平均升高,ET、TXB2水平均下降)改善,同組比較,統(tǒng)計(jì)學(xué)差異顯著(P0.01);組間比較,研究組NO、6-keto-PGF1α水平升高更明顯(P0.05),ET、TXB2水平下降更明顯(P0.05)。5.兩組患者治療后IL-18、Copeptin和hs-CRP水平均顯著下降(P0.01);組間比較,研究組IL-18、copeptin和hs-CRP水平下降更顯著(P0.01)。結(jié)論:1.益腎活血解毒湯聯(lián)合常規(guī)西藥治療較單純西藥治療對(duì)腎虛血瘀型老年冠心病不穩(wěn)定型心絞痛的療效更確切,對(duì)患者中醫(yī)證候改善、減少硝酸甘油用量方面,療效優(yōu)于常規(guī)西藥治療。對(duì)患者心絞痛癥狀及靜息ECG表現(xiàn)均有一定程度改善,但組間差異無(wú)統(tǒng)計(jì)學(xué)意義(P㧐0.05)。2.益腎活血解毒湯聯(lián)合常規(guī)西藥治療腎虛血瘀型老年冠心病不穩(wěn)定型心絞痛能顯著改善患者的血管內(nèi)皮功能(升高NO、6-keto-PGF1α水平,降低ET、TXB2水平)、IL-18、Copeptin和hs-CRP等指標(biāo)。說(shuō)明益腎活血解毒湯具有改善血管內(nèi)皮功能、保護(hù)血管內(nèi)膜及抑制炎癥反應(yīng)等功能,產(chǎn)生穩(wěn)定動(dòng)脈粥樣硬化斑塊的作用,達(dá)到治療老年冠心病不穩(wěn)定型心絞痛的目的。
[Abstract]:Objective: to observe the clinical effect of Yishen Huoxue jiedu decoction on unstable angina pectoris of coronary heart disease (CHD) in elderly patients, and to observe the effect of Yishen Huoxue jiedu decoction on vascular endothelial function, IL-18, and peptide (Copeptin), hs-CRP in order to explore its mechanism. Methods: 40 patients with unstable angina pectoris (kidney deficiency and blood stasis type) were divided into two groups according to the method of random digital table, 20 cases in the study group and 20 cases in the control group according to the criteria of western medicine diagnosis and TCM syndrome diagnosis of UA. The control group was treated with routine western medicine and the study group was treated with Yishen Huoxue jiedu decoction for 4 weeks. Observe the two groups of patients before and after treatment of clinical efficacy and related laboratory indicators change results: 1. The symptoms of angina pectoris and resting ECG were improved in both groups. The total effective rate (95%) in the study group was higher than that in the control group (80%), the total effective rate in the study group (80%) was higher than that in the control group (70%), but there was no significant difference between the two groups (P0. 05). 2. Two groups of patients after treatment of TCM syndrome score significantly decreased, the difference was statistically significant (P0.05); after treatment, the study group than the control group syndrome score decreased more significantly (P0.01). After treatment, the dosage of nitroglycerin was decreased in both groups. The total reduction rate (90%) in the study group was higher than that in the control group (50%), the difference was statistically significant (P0.05). 4 the vascular endothelial function (NO,6-keto-PGF1 偽 level was increased and ET,TXB2 level was decreased) in the two groups. In the same group, the statistical difference was significant (P0.01), and the level of NO,6-keto-PGF1 偽 in the study group was higher than that in the study group (P0.05), and the level of ET,TXB2 decreased more significantly (P0.05). After treatment, the levels of IL-18,Copeptin and hs-CRP decreased significantly in both groups (P0.01), and the levels of IL-18,copeptin and hs-CRP decreased more significantly in the study group than in the control group (P0.01). Conclusion: 1. The therapeutic effect of Yishen Huoxue jiedu decoction combined with conventional western medicine on unstable angina pectoris of coronary heart disease in elderly patients with kidney deficiency and blood stasis is more accurate than that of western medicine alone. It can improve the TCM syndrome of patients and reduce the dosage of nitroglycerin. The curative effect is superior to that of conventional western medicine. The symptoms of angina pectoris and the manifestation of resting ECG were improved to some extent, but there was no significant difference between the two groups (P0. 05). 2. Yishen Huoxue jiedu decoction combined with routine western medicine in the treatment of unstable angina pectoris of coronary heart disease with kidney deficiency and blood stasis can significantly improve vascular endothelial function (raise the level of NO,6-keto-PGF1 偽 and decrease the level of ET,TXB2), IL-18,Copeptin and hs-CRP, etc. It is suggested that Yishen Huoxue jiedu decoction can improve the function of vascular endothelium, protect the intima of blood vessel and inhibit inflammatory reaction, so as to stabilize atherosclerotic plaques and achieve the purpose of treating unstable angina pectoris of coronary heart disease in the elderly.
【學(xué)位授予單位】：安徽中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類(lèi)號(hào)】：R259

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉玉堯;利膽活血解毒湯治療慢性乙型肝炎高膽紅素血癥40例[J];四川中醫(yī);2004年09期

2 趙玲玲;牛浩新;蔡俊剛;韓書(shū)明;;活血解毒湯治療糖尿病足108例[J];中國(guó)中西醫(yī)結(jié)合外科雜志;2011年02期

3 孫謙,孫紅艷;活血解毒湯治療骨折腫脹[J];河南中醫(yī);2000年06期

4 趙歲錄;養(yǎng)肝活血解毒湯治療慢性乙型肝炎43例[J];陜西中醫(yī);2001年07期

5 葉紅娟;;自擬活血解毒湯保留灌腸治療慢性盆腔炎84例[J];中醫(yī)藥臨床雜志;2006年06期

6 何淑嫻;余蓉;葉秀琳;張?jiān)势?;活血解毒湯治療急性冠脈綜合征30例療效觀(guān)察[J];新中醫(yī);2007年08期

7 劉玉堯;;利膽活血解毒湯治療肝炎后高膽紅素血癥32例[J];中外婦兒健康;2011年08期

8 劉玉堯;;自擬利膽活血解毒湯治療肝炎后高膽紅素血癥32例[J];國(guó)醫(yī)論壇;2012年05期

9 王蘭根;周玉峰;;活血解毒湯治療扁平疣[J];河北中醫(yī);1985年02期

10 喻海泉;“活血解毒湯”在創(chuàng)傷中的運(yùn)用[J];時(shí)珍國(guó)藥研究;1991年03期

相關(guān)會(huì)議論文 前5條

1 李江萬(wàn);林岳平;;活血解毒湯治療閉合外傷引起的急性骨髓炎38例[A];第五次全國(guó)中西醫(yī)結(jié)合骨傷科學(xué)術(shù)交流暨中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)骨傷科專(zhuān)業(yè)委員會(huì)換屆大會(huì)文集[C];2000年

2 陸智慧;;自擬益氣活血解毒湯治療腦梗死48例臨床觀(guān)察[A];2005全國(guó)中醫(yī)腦病學(xué)術(shù)研討會(huì)論文匯編[C];2005年

3 崔乃杰;傅強(qiáng);崔華雷;馮津萍;崔乃強(qiáng);;失血性休克時(shí)細(xì)胞線(xiàn)粒體呼吸功能變化及益氣活血解毒湯防治研究[A];第八屆全國(guó)中西醫(yī)結(jié)合普通外科臨床與基礎(chǔ)學(xué)術(shù)會(huì)議暨全國(guó)中西醫(yī)結(jié)合外科危重病學(xué)習(xí)班論文匯編[C];2003年

4 王新華;汪瀟;;參麥活血解毒湯對(duì)博萊霉素誘導(dǎo)肺纖維化大鼠的干預(yù)作用和機(jī)制[A];2013年浙江省醫(yī)學(xué)會(huì)老年醫(yī)學(xué)學(xué)術(shù)年會(huì)暨國(guó)家級(jí)繼教項(xiàng)目老年人優(yōu)化健康管理研討班論文匯編[C];2013年

5 汪瀟;王新華;蔡宛如;;參麥活血解毒湯抗博萊霉素肺纖維化大鼠氧化損傷的研究[A];2013年浙江省醫(yī)學(xué)會(huì)老年醫(yī)學(xué)學(xué)術(shù)年會(huì)暨國(guó)家級(jí)繼教項(xiàng)目老年人優(yōu)化健康管理研討班論文匯編[C];2013年

相關(guān)碩士學(xué)位論文 前5條

1 苗永賓;益腎活血解毒湯干預(yù)動(dòng)脈粥樣硬化的臨床及實(shí)驗(yàn)研究[D];安徽中醫(yī)藥大學(xué);2015年

2 杜朝陽(yáng);益腎活血解毒湯對(duì)動(dòng)脈粥樣硬化及其相關(guān)炎性因子的實(shí)驗(yàn)和臨床研究[D];安徽中醫(yī)藥大學(xué);2015年

3 劉祥彪;益腎活血解毒湯對(duì)老年冠心病不穩(wěn)定型心絞痛的臨床觀(guān)察及其對(duì)患者血管內(nèi)皮功能、IL-18、和肽素的影響[D];安徽中醫(yī)藥大學(xué);2016年

4 潘胡丹;火針聯(lián)合活血解毒湯治療斑塊型銀屑病的臨床研究[D];北京中醫(yī)藥大學(xué);2014年

5 曹翔;益腎活血解毒湯對(duì)老年冠心病心絞痛患者臨床研究及對(duì)血脂、vWF、P-選擇素、HCY的影響[D];安徽中醫(yī)藥大學(xué);2014年

，

本文編號(hào)：2293414